Desai M, Jimenez G, Wijewardane P, Lan L, et al. Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults >/=60 Years of Age. J Infect Dis 2026 Jul 9:jiag350. doi: 10.1093.
PMID: 42419724